Investor Kit

Company Profile

Founded in 1995, Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders.

Acorda has an industry leading pipeline of novel neurological therapies addressing a range of disorders, including Parkinson's disease, migraine and multiple sclerosis. Acorda markets two FDA-approved therapies, including INBRIJA™ (levodopa inhalation powder).

Stock Chart


Date Filing Description Download
05/07/19 10-Q Quarterly Report
05/02/19 8-K Current report filing
04/26/19 DEF 14A Proxy Statement (definitive)
03/12/19 4 Statement of Changes in Beneficial Ownership

Stock Quote

ACOR (Common Stock) $ 10.76 -0.26 (-2.36%) Volume: 648,241 MORE May 20, 2019

Email Alerts

Un-subscribe from email alerts
Email Address *
Mailing Lists *

Enter the code shown above.